This study investigated the role of eltrombopag in regulating metastasis-related genes during breast cancer metastasis through HuR and verified the in vivo anti-metastasis activity of eltrombopag, which may accelerate the clinical application of HuR inhibitors for cancer therapy. Here, ELAVL1 is linked to breast cancer.